In 2023, the import of Rutoside to the US stood at a certain baseline. The forecasted data indicates a continued decline from 2024 to 2028. The year-on-year variations show a consistent decrease in volume. From 2024 to 2025, the import volume is expected to decrease by approximately 6.26%; from 2025 to 2026, by about 6.55%; 2026 to 2027 sees a 6.85% decline; and 2027 to 2028, another 7.23% drop. The Compound Annual Growth Rate (CAGR) reflects a continuous negative trend.

Future trends to monitor include:

Shifts in demand for nutritional supplements and herbal extracts in response to consumer health trends.
Changes in trade regulations or tariffs that may affect import volumes.
Potential development of alternative sources or synthetic substitutes that could impact the need for Rutoside imports.